Pace Locator develops a system that generates 3D maps of cardiac signal origins using ECG and ECHO data, enhanced by a specialized esophageal catheter that captures distinct atrial signals. This technology enables rapid localization of cardiac arrhythmias and optimal placement of cardiac implantable electronic device (CIED) leads, improving treatment planning and reducing surgical time.
Funding
$160K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for mapping cardiac electrical activity and guiding lead placement during cardiac implantable electronic device (CIED) procedures rely on invasive techniques and lack precise 3D visualization. This can lead to suboptimal lead placement, prolonged surgical times, and increased risk of complications.
Solution
Pace Locator offers a non-invasive system that generates 3D maps of cardiac signal origins by integrating ECG and ECHO data. A specialized esophageal catheter captures distinct atrial signals, providing enhanced cardiac activation information compared to surface ECG alone. This technology enables rapid localization of cardiac arrhythmias and visualization of CIED lead location, facilitating optimized treatment planning and reducing surgical time. The system aims to improve the accuracy and efficiency of cardiac procedures, leading to better patient outcomes.
Target Audience
The primary target audience includes electrophysiologists, cardiologists, and surgeons involved in cardiac arrhythmia management and CIED implantation procedures.
Features
- Generates 3D maps of cardiac signal origin from ECG and ECHO data
- Employs a specialized esophageal catheter to capture distinct atrial signals
- Enables rapid localization of cardiac arrhythmias
- Visualizes CIED lead location for optimal placement
- Provides enhanced cardiac activation information compared to surface ECG alone